Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Tasker

Showing results (61-70 of 93) with videos related to

Pageof 10
Sort By:
Journal of Clinical Microbiology|August 9, 2003
Phylogenetic analysis of hemoplasma species: an international studyS Tasker, C R Helps, M J Day, et al.
Journal of Medicinal Chemistry|December 2, 1999
Discovery of a series of cyclohexylethylamine-containing protein farnesyltransferase inhibitors exhibiting potent cellular activityK J Henry, J Wasicak, A S Tasker, et al.
Bioorganic & Medicinal Chemistry Letters|December 27, 2011
Identification of triazolopyridazinones as potent p38α inhibitorsBrad Herberich, Claire Jackson, Ryan P Wurz, et al.
Veterinary Microbiology|August 4, 2009
Development and use of real-time PCR to detect and quantify Mycoplasma haemocanis and "Candidatus Mycoplasma haematoparvum" in dogsE N Barker, S Tasker, M J Day, et al.
Journal of Medicinal Chemistry|September 10, 1999
Pyrrolidine-3-carboxylic acids as endothelin antagonists. 4. Side chain conformational restriction leads to ET(B) selectivityT W von Geldern, A S Tasker, B K Sorensen, et al.
Bioorganic & Medicinal Chemistry Letters|February 9, 2010
Part 2: Structure-activity relationship (SAR) investigations of fused pyrazoles as potent, selective and orally available inhibitors of p38alpha mitogen-activated protein kinaseRyan P Wurz, Liping H Pettus, Bradley Henkle, et al.
Journal of Medicinal Chemistry|January 31, 1997
Potent and selective non-benzodioxole-containing endothelin-A receptor antagonistsA S Tasker, B K Sorensen, H S Jae, et al.
Bioorganic & Medicinal Chemistry Letters|July 4, 2009
Part 1: Structure-Activity Relationship (SAR) investigations of fused pyrazoles as potent, selective and orally available inhibitors of p38alpha mitogen-activated protein kinaseRyan P Wurz, Liping H Pettus, Shimin Xu, et al.
Journal of Medicinal Chemistry|August 18, 2010
Discovery of pyridazinopyridinones as potent and selective p38 mitogen-activated protein kinase inhibitorsBin Wu, Hui-Ling Wang, Liping Pettus, et al.
Bioorganic & Medicinal Chemistry Letters|August 30, 2008
Discovery of amido-benzisoxazoles as potent c-Kit inhibitorsRoxanne K Kunz, Shannon Rumfelt, Ning Chen, et al.
Pageof 10

Showing results (61-70 of 93) with videos related to

Sort By:
Pageof 10
Journal of Clinical Microbiology|August 9, 2003
Phylogenetic analysis of hemoplasma species: an international studyS Tasker, C R Helps, M J Day, et al.
Journal of Medicinal Chemistry|December 2, 1999
Discovery of a series of cyclohexylethylamine-containing protein farnesyltransferase inhibitors exhibiting potent cellular activityK J Henry, J Wasicak, A S Tasker, et al.
Bioorganic & Medicinal Chemistry Letters|December 27, 2011
Identification of triazolopyridazinones as potent p38α inhibitorsBrad Herberich, Claire Jackson, Ryan P Wurz, et al.
Veterinary Microbiology|August 4, 2009
Development and use of real-time PCR to detect and quantify Mycoplasma haemocanis and "Candidatus Mycoplasma haematoparvum" in dogsE N Barker, S Tasker, M J Day, et al.
Journal of Medicinal Chemistry|September 10, 1999
Pyrrolidine-3-carboxylic acids as endothelin antagonists. 4. Side chain conformational restriction leads to ET(B) selectivityT W von Geldern, A S Tasker, B K Sorensen, et al.
Bioorganic & Medicinal Chemistry Letters|February 9, 2010
Part 2: Structure-activity relationship (SAR) investigations of fused pyrazoles as potent, selective and orally available inhibitors of p38alpha mitogen-activated protein kinaseRyan P Wurz, Liping H Pettus, Bradley Henkle, et al.
Journal of Medicinal Chemistry|January 31, 1997
Potent and selective non-benzodioxole-containing endothelin-A receptor antagonistsA S Tasker, B K Sorensen, H S Jae, et al.
Bioorganic & Medicinal Chemistry Letters|July 4, 2009
Part 1: Structure-Activity Relationship (SAR) investigations of fused pyrazoles as potent, selective and orally available inhibitors of p38alpha mitogen-activated protein kinaseRyan P Wurz, Liping H Pettus, Shimin Xu, et al.
Journal of Medicinal Chemistry|August 18, 2010
Discovery of pyridazinopyridinones as potent and selective p38 mitogen-activated protein kinase inhibitorsBin Wu, Hui-Ling Wang, Liping Pettus, et al.
Bioorganic & Medicinal Chemistry Letters|August 30, 2008
Discovery of amido-benzisoxazoles as potent c-Kit inhibitorsRoxanne K Kunz, Shannon Rumfelt, Ning Chen, et al.
Pageof 10